Search clinical trials for: BAY86-4891 (Estradiol / Drospirenone)

Total 98 results

Bayer

Completed

Angeliq Regulatory Post Marketing Surveillance (Angeliq rPMS)

Osteoporosis, Postmenopausal | Postmenopausal Period

Korea, Republic of
Bayer

Completed

Treatment of Vasomotor Symptoms in Korean Post Menopausal Women

Vasomotor Symptoms

Korea, Republic of
Bayer

Completed

Low-dose Hormone Therapy for Relief of Vasomotor Symptoms

Vasomotor Symptoms | Hot Flashes

United States
Bayer

Completed

A Study to Evaluate Inhibition of Ovulation of Two Oral Estrogen/Progestogen Regimens in Healthy, Young Females Over a Period of 3 Treatment Cycles

Contraception

Germany
Bayer

Completed

Effect of Angeliq on Blood Pressure (BP) in Postmenopausal Hypertensive Women

Hypertension | Postmenopause
Bayer

Completed

Safety/Efficacy Study of Drospirenone/Estradiol to Treat Postmenopausal Chinese Women With Vasomotor Symptoms.

Vasomotor Symptoms

China
Bayer

Completed

Efficacy and Tolerability of Angeliq in Thai Women

Postmenopause
Bayer

Completed

Effects of Angeliq and Prempro on Blood Pressure and Sodium Sensitivity in Postmenopausal Women With Prehypertension

Hypertension | Postmenopause | Pre-Hypertension

United States
Bayer

Completed

A Prospective Multicenter Study on Patients'Satisfaction With Angeliq® Micro in Real Clinical Practice Conducted in Russia

Menopause

Russian Federation
Bayer

Completed

Yasmin Post Marketing Surveillance

Contraception

Korea, Republic of
Bayer

Completed

LCS16 vs. COC User Satisfaction and Tolerability Study

Contraception

Russian Federation
Bayer

Completed

Effects of Counseling on the Continuation Rates and Compliance for Newly Prescribed Oral Contraceptives (Yasmin® or Any Other Oral Contraceptives (OC)

Contraception

Saudi Arabia, Jordan, Lebanon, Bahrain, Kuwait, Oman, Qatar, Hungary, Albania, Egypt, Kenya, Macedonia, The Former Yugoslav Republic of, United Arab Emirates
NewAmsterdam Pharma
Novum

Recruiting

Evaluate the Pharmacokinetics of a Combined Oral Contraceptive (COC) With and Without Obicetrapib

Healthy Volunteers

United States
Teva Pharmaceuticals USA

Completed

Drospirenone/Ethinyl Estradiol (3 mg/0.02 mg) Tablets Under Non-Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Drospirenone/Ethinyl Estradiol (3 mg/0.02 mg) Tablets Under Fasting Conditions.

Healthy

United States
Bio-innova Co., Ltd

Not yet recruiting

Drospirenone (3 mg) + Ethinyl Estradiol (0.03 mg) Tablets Relative to Yasmin®

Healthy Subjects
AGUNCO Obstetrics and Gynecology Centre

Completed

Clinical, Metabolic and Endocrine Effects of the Treatment With Drospirenone and Ethinyl Estradiol Alone or in Combination With Myo-inositol in Young Women With Polycystic Ovary Syndrome (PCOS) and Insulin Resistance

Polycystic Ovary Syndrome | PCOS

Italy
Bayer

Completed

Study to Investigate the Effect of Missed Pills on Follicular Development in Two Application Regimens of SH T 00186 D

Contraceptives, Oral

Netherlands
Bristol-Myers Squibb

Completed

A Study to Investigate the Effects of BMS-986278 on Drospirenone and Ethinyl Estradiol Drug Levels in Healthy Female Participants

Healthy Volunteers

Canada
Bio-innova Co., Ltd

Recruiting

Drospirenone (3 mg) + Ethinyl Estradiol (0.02 mg) Tablets Relative to Yaz®

Healthy Subjects

Thailand
Catholic University of the Sacred Heart

Completed

Effect of Two Different Dosages of Ethinyl-estradiol in Association With Drospirenone in Women With Polycystic Ovary Syndrome.

Polycystic Ovary Syndrome | Estro-progestin Drugs

Italy
Bayer
University of California, San Francisco; Laboratorium für Klinische Forschung; Diagnostic Cytology Laboratory

Completed

Endometrial Safety Study

Postmenopause

Mexico, United States, Italy, Denmark, Austria, Argentina, Brazil, Russian Federation
Massachusetts General Hospital
Bayer

Completed

The Oral Contraceptive Pill for Premenstrual Worsening of Depression

Depression | Premenstrual Syndrome

United States
Massachusetts General Hospital
Bayer

Completed

Safety and Efficacy Of Drospirenone and Ethinyl Estradiol vs Placebo in the Treatment of Truncal Acne

Acne Vulgaris

United States
Ortho-McNeil Janssen Scientific Affairs, LLC

Completed

Study to Evaluate Cycle Control With Norgestimate/Ethinyl Estradiol and Drospirenone/Ethinyl Estradiol in Healthy Sexually Active Females

Contraception
University of North Carolina, Chapel Hill
Foundation of Hope, North Carolina

Terminated

Binge Eating & Birth Control

Binge-Eating Disorder | Bulimia Nervosa | Binge Eating | Eating Disorders

United States
Silva Arslanian
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Completed

Insulin Resistance, Polycystic Ovary Syndrome, and Bone Research Study

Polycystic Ovary Syndrome

United States
Navy General Hospital, Beijing

Unknown

Oral Contraceptives as Infertility Treatments for Premature Ovarian Failure

Primary Ovarian Insufficiency | Menopause, Premature

China
Massachusetts General Hospital
Bayer

Terminated

A Study to Examine the Safety and Efficacy of Drospirenone and Ethinyl Estradiol (YAZ) Versus Placebo In HS

Hidradenitis Suppurativa

United States
Brigham and Women's Hospital
Bayer

Completed

Effect of Estradiol+Drospirenone Versus Estradiol+MPA on Endothelial Function

Cardiovascular Diseases

United States
National Institute of Mental Health (NIMH)

Terminated

Treatment of Menstrually Related Disorders With Continuous v. Interrupted Oral Contraceptives

Depression | Premenstrual Dysphoric Disorder | Premenstrual Syndrome | PMS | PMDD

United States
NewGiza University
Ain Shams University

Not yet recruiting

The Association of Hormonal Intake and Demographic Factors With Breast Cancer Risk. An Egyptian Case-controlled Study

Observational Study
Ain Shams Maternity Hospital

Unknown

Levonorgestrel-releasing Intrauterine System Versus a Low-dose Combined Oral Contraceptive for Management of Adenomyosis Uteri (LNG-IUDvsCOCs)

Adenomyosis

Egypt
Denusa Wiltgen
Hospital de Clinicas de Porto Alegre; Coordenação de Aperfeiçoamento de Pessoal... and other collaborators

Completed

Pharmacogenetic Study of Different Hormone Therapies in Recent Menopause Women

Postmenopause

Brazil
Bayer

Completed

Efficacy and Safety Study for an Oral Contraceptive Containing Folate

Contraception | Neural Tube Defects | Oral Contraceptives (OC)

United States
Bayer

Completed

Cycle Control and Safety of E2-DRSP

Contraceptive, Oral, Hormonal

Germany
Bayer

Completed

GA YAZ ACNE in China Phase III

Acne Vulgaris

China
University of Palermo
University of Roma La Sapienza

Completed

The Use of Drospirenone/Estetrol, Nomegestrol Acetate/Estradiol and Ethinylestradiol/Dienogest in Random Start Rapid Endometrial Preparation

Endometrial Polyp | Endometrial Diseases

Italy
Guangdong Women and Children Hospital

Recruiting

Efficacy and Safety of Dingkundan Combined With Combination Oral Contraceptives in the Treatment of PCOS

PCOS

China
St. Joseph's Healthcare Hamilton
McMaster University; Hamilton Academic Health Sciences Organization

Recruiting

Oral Contraceptives for Treating Premenstrual Dysphoric Disorder in Bipolar Disorder

Bipolar Disorder | Premenstrual Dysphoric Disorder

Canada
Istanbul Training and Research Hospital

Withdrawn

Comparison of Levonorgestrel Intrauterine System, Copper T Intrauterine Device and Oral Contraceptives on Life Quality

Contraceptive Methods Comparison

Turkey
University of California, San Francisco

Completed

Continuous Versus Cyclical OCP Use in PCOS (CCOUP)

Polycystic Ovary Syndrome

United States
Janssen Research & Development, LLC

Terminated

A Study to Investigate the Interaction Between JNJ-64155806 and Ethinylestradiol/Drospirenone in Healthy Females

Healthy

United States
Bayer

Completed

Study to Evaluate the Effect of Six Cycles of Treatment With a Combined Oral Contraceptive (EE 0.30 mg/DRSP 3 mg) on Quality of Life.

Healthy
Catholic University of the Sacred Heart

Unknown

Effects of Drospirenone-ethinylestradiol and/or NOMAC-valerate Estradiol on Cardiovascular Risk in Women With Polycystic Ovary Syndrome

Polycystic Ovary Syndrome

Italy
Tyumen State Medical Academy

Unknown

Hemocoagulation and Lipoperoxidation in Women Using Combined Oral Contraceptives, Correction by Antioxidants

Hyperandrogenism | Polycystic Ovarian Syndrome | Menstrual Irregularities

Russian Federation
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

A Study to Evaluate Ovarian Follicular Activity and Hormone Levels for DR-102 Compared to Two 28-Day Oral Contraceptives

Oral Contraceptive | Follicle Development | Ovarian Follicle | Follicle Count | Follicle Size

United States
Bayer

Completed

Efficacy and Safety of Two Flexible Extended Regimens of BAY86-5300 (SH T00186D) in Comparison With the Conventional Regimen of YAZ

Contraception | Ovulation Inhibition | Contraceptives, Oral

United States
Boehringer Ingelheim

Terminated

A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood

Healthy

Germany
ViiV Healthcare
GlaxoSmithKline

Terminated

A Study to Evaluate the Pharmacokinetics of an Oral Contraceptive When Co-administered With GSK2248761 in Healthy Adult Female Subjects.

HIV Infections | Infection, Human Immunodeficiency Virus

United States

3

Subscribe